SLC3A2 and Burkitt lymphoma: Wilson et al.58 used a transgenic mouse model in which EBNA-1 was expressed under the control of the mouse Ig heavy chain intronic enhancer, and their experimental results demonstrated that EBNA-1 is oncogenic in vivo and may directly participate in the mechanisms underlying the development of Burkitt’s lymphoma and other EBV-associated malignancies.